• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Geron Corporation - Common Stock (NQ:GERN)

1.005 +0.055 (+5.79%)
Delayed Quote Updated: 1:13 PM EST, Nov 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,762,487
Open 0.9500
Bid (Size) 1.000 (5,800)
Ask (Size) 1.010 (9,800)
Prev. Close 0.9500
Today's Range 0.9500 - 1.020
52wk Range 0.8400 - 2.010
Shares Outstanding 508,766,846
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Geron: 3 Key Takeaways for Long-Term Investors ↗
November 05, 2026
Operating expenses fell 9% year to date, and $339 million in cash leaves Geron room to pursue hematology deals. 
Via The Motley Fool
Topics Earnings
News headline image
Geron Corp (GERN) Q3 2026 Earnings Call Transcript ↗
November 04, 2026
First profit as a commercial-stage biotech, on RYTELO growth and cost cuts. 
Via The Motley Fool
Topics Earnings

Performance

52-Week Range 50.0% below 52-week high
1.005
0.8452W Low 2.0152W High
1 Week 7.8% below 1-week high
0.861W Low 1.091W High

Geron Corporation - Common Stock (GERN) traded between $0.84 and $2.01 over the past 52 weeks and last traded at $1.00, 50.0% below its 52-week high. Over the past week it ranged between $0.86 and $1.09.

Past 12 Months
+12.4%
-16.9%
-36.0%
-31.2%
-23.9%
-7.8%
1W +$0.11
1M -$0.21
3M -$0.57
6M -$0.46
YTD -$0.32
1Y -$0.09

GERN was -7.8% over the past year, -31.2% over six months, -23.9% year to date, +12.4% in the last week.

12 Months vs Market
GERN
-7.8%
DIA
+8.7%
SPY
+8.8%
QQQ
+5.3%
IWM
+11.8%

Over the past 12 months GERN returned -7.8% versus DIA (Dow) +8.7%, SPY (S&P 500) +8.8%, QQQ (Nasdaq 100) +5.3% and IWM (Russell 2000) +11.8%.

Volume & Liquidity 0.55× 3-mo avg
Today 6,762,487 3-mo avg 12.3M
1W
28.8M
1M
15.9M
3M
12.3M
6M
12.7M
YTD
14.3M
1Y
13.3M

GERN most recently traded 6,762,487 shares against a 3-month average daily volume of 12.3M.

More News

Read More
News headline image
Geron Q3 Earnings Call Highlights ↗
November 04, 2026
Via MarketBeat
Topics Earnings
Geron (NASDAQ:GERN) Falls After Mixed Q2 Results; Revenue Beats but Loss Wider Than Expected ↗
August 05, 2026
Via Chartmill
Geron Corp. (NASDAQ:GERN) Beats Q1 Estimates as RYTELO Sales Momentum Continues ↗
May 06, 2026
Via Chartmill
Geron Corp (NASDAQ:GERN) Stock Plummets 10% After Q4 Revenue Miss ↗
February 25, 2026
Via Chartmill
News headline image
Earnings Scheduled For November 5, 2025 ↗
November 05, 2025
Via Benzinga
News headline image
Geron Earnings Preview ↗
November 04, 2025
Via Benzinga
Most Active Stocks in the 2026-10-28 US Session ↗
October 28, 2026
Via Chartmill
News headline image
Geron Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Geron Corporation - GERN
October 12, 2026
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Klotho Protein Emerges as a Potential Powerhouse In the Next Generation of Longevity Medicine
September 30, 2026
Via FinancialNewsMedia
News headline image
Geron Eyes High End of 2026 RYTELO Revenue Guidance as Community Adoption Expands ↗
September 16, 2026
Via MarketBeat
News headline image
Geron Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Geron Corporation - GERN
September 14, 2026
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Geron Sees RYTELO Revenue Near High End of 2026 Guidance as Community Use Expands ↗
September 13, 2026
Via MarketBeat
News headline image
Geron (GERN) Q2 2026 Earnings Call Transcript ↗
August 06, 2026
Via The Motley Fool
Topics Earnings
News headline image
Geron Q2 Earnings Call Highlights ↗
August 05, 2026
Via MarketBeat
Topics Earnings
News headline image
Cell-Based Therapies Poised to Disrupt Multi-Billion-Dollar Anti-Aging and Neurodegenerative Markets
May 20, 2026
Via FinancialNewsMedia
News headline image
Geron (GERN) Q1 2026 Earnings Call Transcript ↗
May 07, 2026
Via The Motley Fool
Topics Earnings Economy
News headline image
Investors Eye Explosive Growth in Anti-Aging Therapies as Market Targets $420B Milestone
March 03, 2026
Via FinancialNewsMedia
Here are the top movers in Wednesday's session. ↗
February 25, 2026
Via Chartmill
News headline image
Geron (GERN) Q4 2025 Earnings Call Transcript ↗
February 25, 2026
Via The Motley Fool
Topics Earnings
Which stocks are moving before the opening bell on Wednesday? ↗
February 25, 2026
Via Chartmill
News headline image
Why Did GERN Stock Tumble 10% Pre-Market Today? ↗
February 25, 2026
Via Stocktwits
Topics Artificial Intelligence
News headline image
Geron Corp (NASDAQ:GERN) Reports Mixed Q3 2025 Results, Misses Revenue Estimates ↗
November 05, 2025
Via Chartmill
News headline image
Geron Corporation Reports Third Quarter 2025 Financial Results and Recent Business Highlights
November 05, 2025
From Geron Corporation
Via Business Wire

Frequently Asked Questions

Is Geron Corporation - Common Stock publicly traded?
Yes, Geron Corporation - Common Stock is publicly traded.
What exchange does Geron Corporation - Common Stock trade on?
Geron Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Geron Corporation - Common Stock?
The ticker symbol for Geron Corporation - Common Stock is GERN on the Nasdaq Stock Market
What is the current price of Geron Corporation - Common Stock?
The current price of Geron Corporation - Common Stock is 1.005
When was Geron Corporation - Common Stock last traded?
The last trade of Geron Corporation - Common Stock was at 11/06/26 01:13 PM ET
What is the market capitalization of Geron Corporation - Common Stock?
The market capitalization of Geron Corporation - Common Stock is 511.31M
How many shares of Geron Corporation - Common Stock are outstanding?
Geron Corporation - Common Stock has 511M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap